Compounding pharmacy Roseway Labs has announced it will be distributing its products to prescribers across the European Union (EU).
Roseway Labs explains that it offers bioidentical hormone replacement therapy (BHRT), skincare and hair loss solutions, plus medication for pain management, allergies and intolerances or nutrition.
The company shares that once regulatory work has been completed, a new base will be opened in the Netherlands in Spring 2024.
Chief executive officer Elizabeth Philp commented, “Our market is prescribers with the right attitude who want something that really fits their patients. People who think differently and who want to access something different, to provide a truly personalised service to support their patients’ health and wellness. We are excited at the prospect of bringing our services to prescribers in the EU and look forward to building new relationships.”
